21Shares Launches Europe's First Zcash ETP as ZEC Breaks $1,600
Asset manager 21Shares listed Europe's first Zcash exchange-traded product on Euronext Paris and Amsterdam this week, expanding regulated access to ZEC across the continent. The debut coincided with Zcash climbing past $1,600, the highest level this year, as shielded ZEC holdings reached 29% of circulating supply.
Written by CoinArticle’s AI Newsroom · from 2 cited sources. How we work
Regulated Access Expands to Europe
21Shares launched a physically backed Zcash ETP on Euronext Paris and Amsterdam this week, marking the first regulated exchange-traded product for ZEC in Europe. The move mirrors earlier U.S. spot Bitcoin and Ethereum ETF approvals and gives European institutional and retail investors direct exposure to Zcash without holding the asset directly or navigating decentralized exchanges.
Price and Privacy Metrics Move in Tandem
Zcash climbed past $1,600 following the ETP launch, according to The Defiant, marking the asset's highest level in 2024. On-chain data captured at 3:42 p.m. ET showed shielded ZEC—coins held in Zcash's privacy-preserving address pools—comprising 29% of circulating supply, a notable shift given historical adoption of transparent addresses. The combination of regulated custody options and increased privacy pool activity suggests growing confidence among both institutional and privacy-conscious holders.
Why It Matters
For Traders
ZEC broke $1,600 intraday after the ETP launch; watch Euronext volume and institutional inflow data over the next two weeks to gauge sustained demand.
For Investors
Regulated custody and ETF access historically precede deeper institutional adoption and reduce counterparty risk for long-term holders seeking exposure without self-custody.
For Builders
Rising shielded address adoption (29% of supply) indicates market preference for privacy features, signaling demand for interoperability between privacy pools and institutional settlement rails.
This article is for information only and is not financial advice. Read the full disclaimer.
